Gujarat Alkalies Q1 FY27 Results: Profit After Tax ₹53.40 Crore, Approves HCL Unit
Gujarat Alkalies and Chemicals Limited reported standalone and consolidated un-audited results for Q1 FY27. Profit After Tax stood at ₹53.40 crore. The Board approved an HCL synthesis unit at Dahej with a project cost of ₹55 crore. Vision 2047 document was also approved.
The approval of a new project with a significant cost and positive financial results suggest a moderate impact on the company's future performance and investor outlook.
The company reported positive financial results and approved a new project, indicating growth and strategic expansion.
Gujarat Alkalies and Chemicals Limited announced its standalone and consolidated un-audited financial results for the quarter ended June 30, 2026. The company reported a Profit After Tax of ₹53.40 crore for the quarter. The Board of Directors also granted in-principle approval for an additional HCL synthesis unit at Dahej with an approximate project cost of ₹55 crore. This unit is expected to enhance chlorine utilization and optimize caustic soda production. The generated HCL will be utilized in the proposed Phosphoric Acid plant at Dahej. The Board also approved the company's Vision 2047 document. The Board Meeting commenced at 03:30 PM and concluded at 05:00 PM on July 23, 2026.
The standalone revenue from operations for the quarter stood at ₹1,24,491 lakh, with a profit before tax of ₹11,004 lakh. The consolidated revenue from operations was also ₹1,24,491 lakh, with a profit before tax of ₹11,162 lakh. The company's total comprehensive income for the period was ₹18,756 lakh on a standalone basis and ₹18,914 lakh on a consolidated basis. The financial results have been prepared in accordance with Indian Accounting Standards (Ind AS) and have been reviewed by the Audit Committee and approved by the Board of Directors.
What to do with a filing like this
Gujarat Alkalies and Chemicals Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Gujarat Alkalies and Chemicals Limited. Read the original for the full detail.